Efficacy and safety of nesiritide in patients with acute decompensated heart failure

Expert Review of Cardiovascular Therapy
Tracy A DeWald, Adrian F Hernandez

Abstract

Acute decompensated heart failure is a common clinical problem with associated poor outcomes. Over the last decade, attention to this area has greatly increased, with a focus on medical therapies that may safely offer improvement in acute symptoms and early outcomes. Previous therapies that focused on increased inotropy have generally failed to improve symptoms without adverse consequences. Thus, attention towards vasodilators and natriuretic peptides, such as nesiritide, has increased owing to nesiritide's symptomatic improvement and unique mechanism of improvement in hemodynamics. However, the pathophysiology of acute decompensated heart failure is complex and the impact of nesiritide on important clinical end points, beyond symptomatic and hemodynamic improvement, is unknown.

References

Feb 28, 1974·The New England Journal of Medicine·A Ramírez, W H Abelmann
Apr 18, 2000·Heart·J J McMurray, S Stewart
Jul 31, 2001·Cardiovascular Research·T SuzukiY Yazaki
Oct 5, 2001·Journal of the American College of Cardiology·A Al-AhmadM J Sarnak
Mar 28, 2002·JAMA : the Journal of the American Medical Association·Michael S CuffeUNKNOWN Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigato
May 30, 2002·European Journal of Heart Failure·Simon StewartJohn J J V McMurray
Dec 18, 2002·American Heart Journal·Andrew J BurgerUNKNOWN Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy
Feb 21, 2003·American Heart Journal·G Michael FelkerMihai Gheorghiade
Jan 23, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Javed ButlerUNKNOWN VMAC study investigators
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Gregg C FonarowUNKNOWN ADHERE Scientific Advisory Committee, Study Group, and Investigators
Feb 22, 2005·Congestive Heart Failure·Andrew J Burger
Mar 23, 2005·Circulation·Jonathan D Sackner-BernsteinKeith D Aaronson
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Jonathan D Sackner-BernsteinKeith Aaronson
Jul 5, 2005·Expert Opinion on Investigational Drugs·R E Hobbs, R M Mills
Sep 9, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·William T MahleJanet M Simsic
Sep 27, 2005·The Journal of Emergency Medicine·W F PeacockC L Emerman
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Feb 28, 2006·Journal of Cardiac Failure·UNKNOWN Heart Failure Society Of America
Jul 11, 2006·The American Journal of Medicine·Mikhail KosiborodHarlan M Krumholz
Aug 1, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jose IglesiasJerrold S Levine
Sep 27, 2006·European Heart Journal·Markku S NieminenUNKNOWN Heart Failure Association, European Society of Cardiology
Oct 19, 2006·The Journal of Emergency Medicine·W Frank Peacock
Feb 13, 2007·Journal of the American College of Cardiology·Robert M MentzerUNKNOWN NAPA Investigators
Mar 14, 2007·Journal of the American College of Cardiology·Horng H Chen
Sep 11, 2007·Journal of Cardiac Failure·John L JefferiesJeffrey A Towbin
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Sep 9, 2011·European Journal of Clinical Pharmacology·Natig GassanovFikret Er

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.